abstract |
The present invention provides methods for treating, preventing, and / or alleviating neurodegenerative diseases associated with a kinase mutation, including neurodegenerative diseases associated with BRAFV600E, in a subject in need thereof. In particular aspects, the present technology relates to the use of BRAF, MEK and / or CSF-IR inhibitors for treating, preventing and / or ameliorating neurodegenerative diseases associated with kinase mutation, including neurodegenerative diseases associated with BRAFV600E. |